Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Kazia Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Zelira, PolyNovo prove even a pandemic can’t stand in the way of good clinical results
Health & Biotech
Health: Neuren’s mice are happily burying marbles after PMS neurotherapy
Health & Biotech
Brain health is complicated, but these ASX small caps are trying to keep it in shape
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Health & Biotech
Health: GTG back in with breast cancer, hopes to start sales next year
Health & Biotech
Biotech: Cynata wins first round against sepsis bugs
Health & Biotech
Check up: Here’s what’s happening with ASX small cap health stocks
News
Lunchtime ASX small cap wrap: Who’s feeling presidential today?
Health & Biotech
Health: Botanix buddy set to benefit after DEA admits their synthetic CBD is probably ok
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
90 Seconds With...
VIDEO: 90 Seconds With… Dr. James Garner, Kazia Therapeutics
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
Health & Biotech
The Health Kick Podcast with Tim Boreham: Kazia Therapeutics
Health & Biotech
Health: Tech giant IBM integrates Total Brain’s mental health tech to help vets
Health & Biotech
Health: This mouthguard maker is now kicking off medicinal cannabis trials
Health & Biotech
